|
Report Date : |
04.12.2013 |
IDENTIFICATION DETAILS
|
Name : |
JAWA PHARMACEUTICALS (PVT) LIMITED (JPPL) |
|
|
|
|
Registered Office : |
112/10, Quaid-e-Azam Industrial Area, Kot
Lakhpat, Lahore |
|
|
|
|
Country : |
Pakistan |
|
|
|
|
Date of Incorporation : |
22.02.1987 |
|
|
|
|
Com. Reg. No.: |
0015689 |
|
|
|
|
Legal Form : |
Private Limited company |
|
|
|
|
Line of Business : |
Manufacturing of Pharmaceutical Products (Medicines) |
|
|
|
|
No. of Employees : |
27 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2013
|
Country Name |
Previous Rating (31.12.2012) |
Current Rating (31.03.2013) |
|
Pakistan |
B2 |
B2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
PAKISTAN - ECONOMIC
OVERVIEW
Decades of internal political disputes and low levels of
foreign investment have led to slow growth and underdevelopment in Pakistan.
Agriculture accounts for more than one-fifth of output and two-fifths of
employment. Textiles account for most of Pakistan's export earnings, and
Pakistan's failure to expand a viable export base for other manufactures has
left the country vulnerable to shifts in world demand. Official unemployment is
under 6%, but this fails to capture the true picture, because much of the economy
is informal and underemployment remains high. Over the past few years, low
growth and high inflation, led by a spurt in food prices, have increased the
amount of poverty - the UN Human Development Report estimated poverty in 2011
at almost 50% of the population. Inflation has worsened the situation, climbing
from 7.7% in 2007 to almost 12% for 2011, before declining to 10% in 2012. As a
result of political and economic instability, the Pakistani rupee has
depreciated more than 40% since 2007. The government agreed to an International
Monetary Fund Standby Arrangement in November 2008 in response to a balance of
payments crisis. Although the economy has stabilized since the crisis, it has
failed to recover. Foreign investment has not returned, due to investor
concerns related to governance, energy, security, and a slow-down in the global
economy. Remittances from overseas workers, averaging about $1 billion a month
since March 2011, remain a bright spot for Pakistan. However, after a small
current account surplus in fiscal year 2011 (July 2010/June 2011), Pakistan's
current account turned to deficit in fiscal year 2012, spurred by higher prices
for imported oil and lower prices for exported cotton. Pakistan remains stuck
in a low-income, low-growth trap, with growth averaging about 3% per year from
2008 to 2012. Pakistan must address long standing issues related to government
revenues and energy production in order to spur the amount of economic growth
that will be necessary to employ its growing and rapidly urbanizing population,
more than half of which is under 22. Other long term challenges include
expanding investment in education and healthcare, adapting to the effects of
climate change and natural disasters, and reducing dependence on foreign donors
Source
: CIA
JAWA PHARMACEUTICALS (PVT) LIMITED (JPPL)
|
Business Name |
JAWA PHARMACEUTICALS (PVT) LIMITED (JPPL) |
|
Address |
Head Office / Registered Office: 112/10, Quaid-e-Azam Industrial Area, Kot Lakhpat,
Lahore. |
|
Telephone |
(+92) (42) 35142041 - 5, 35111147 |
|
Fax |
(+92) (42) 35110906 |
|
Mobile |
(+92) (321) 4022271 Mr. Muhammad
Baqir Jawa - Director |
|
|
md@jawagroup.com; info@jawagroup.com; import@jawagroup.com; export@jawagroup.com |
|
Website |
|
|
Business activities |
Manufacturing of Pharmaceutical Products (Medicines) |
Registry Details
|
CRO Registration Number |
0015689 |
|
Date of Registration |
February 22, 1987 |
Other registry &
certification details:
|
Current Legal Form |
Private Limited company |
|
National Tax Registration Number |
0786475-2 |
|
Date of Registration |
July 09, 1996 |
|
GST Registration Number |
Undetermined |
|
Date of Registration |
Undetermined |
|
Chamber of Commerce & Industry |
Lahore Chamber of Commerce and Industry |
|
Date of Registration |
Undetermined |
|
ISO Certification |
ISO 9001:2000 |
|
Date of Registration & Expiry |
May 05, 2006 |
|
Other certifications |
None |
|
Date of Registration & Expiry |
None |
Capital
|
Type |
No. of Shares |
Par Value |
Total Value |
|
Authorized |
500,000 |
RS. 100/- |
Rs.50,000,000/- |
|
Issued, Subscribed & Paid-Up |
269,790 |
RS. 100/- |
Rs.26,979,000/- |
History
|
Who started |
Not Disclosed |
|
When started |
1967 |
|
Change in management |
No Change |
|
Year of change |
N/A |
|
Change in legal status |
Not Disclosed |
|
Year of change |
N/A |
|
Change in business address |
Garden town Karachi to Kot Lakhpat Lahore |
|
Year of change |
1982 |
|
Name |
Designation |
Number of Shares |
Nationality |
Appointment Date
(Last) |
|
Mr. Sajid Ali Jawa |
CEO/Director |
141,110 |
Pakistani |
30-09-2009 |
|
Mrs. Saeeda Fatima |
Directors |
25,160 |
Pakistani |
30-09-2009 |
|
Mr. M. Baqir Jawa |
Directors |
51,760 |
Pakistani |
30-09-2009 |
|
Mr. M. Raza Jawa |
Directors |
51,760 |
Pakistani |
30-09-2009 |
|
Name |
Position in organization |
Qualification |
Years in employment |
|
Mr. Sajid Ali Jawa |
Chief Executive Officer |
Not Provided |
|
|
Mr. Abid Raza |
Finance Manager |
8 years |
|
|
Mr. Faisal Suleman |
Marketing Manager |
|
|
|
Mr. Shahzad Hassan |
Company Secretary |
|
|
Statutory offices |
|
|
Statutory
Auditors |
M/s. Phinehas & Co. Chartered Accountants |
|
Legal
Advisory Services |
M/s. Nadeem Nazir Law Associates |
|
Bank name |
Approved financing
limits |
|
Habib
Bank Limited |
67,000,000 |
The primary focus of
the concern is manufacturing of Pharmaceutical Medicines. The company aims to
provide quality pharmaceutical products to serve the country and globally. The company
started on a small scale and has expanded with the demand of the customers
worldwide.
Purchases (Incl.
Imports)
|
Imports from |
India, China |
|
Importing terms |
L/C |
|
Local (%) |
50 |
|
Local buying terms |
30-60 Days credit |
Sales (Incl. Exports)
|
Exports to |
Afghanistan, Myanmar and Sri lanka |
|
Exporting terms |
L/C |
|
Local (%) |
Not Provided |
|
Local selling terms |
Not Provided |
Additional information (Extracts from official website of the organization):
Ambition to get success is a driving force for any noble aim. No ambition can germinate without seed of commitment and light of consistent effort. By grace of God, the immense contribution of Jawa Pharmaceuticals towards the health care of the masses is an unprecedented glittering mark of strenuous effort and consolidated strategies.
Jawa Pharmaceuticals was established with the objective of developing medicines to cure suffering humanity. Its main concern was to earn idea-breeding minds by grasping the finger of progress in the field of science and research.
|
Nature of
employment |
Current Year |
Previous Year |
|
All Staff |
27 |
27 |
|
Total |
27 |
27 |
|
Head office Address Owned / Rented Area (approx) |
112/10, Quaid-e-Azam Industrial Area, Kot
Lakhpat, Lahore Owned Five (5) Kanal |
|
Factory Address Owned / Rented Area (approx) |
Not provided |
|
Warehouse Address Owned / Rented Area (approx) |
Not provided |
During the market check of JPPL, we contacted various suppliers / customers / competitors of the subject company. In their opinion subject company is a good player of the industry and enjoys good reputation in the market. Market sources further mentioned that JPPL is known as a profitable and prosperous business in the industry. No complaints or disputes were reported during the market check.
The contact person declined to share financial information.
|
Contact person |
Mr. Abid |
|
Position |
Manager Finance. |
|
Comments |
Contact person confirmed the business operations; he provided the business information but decline to share the financial information. During physical visit we observed different production and trading activities. Employees were observed busy in their respective tasks. |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.62.34 |
|
|
1 |
Rs.102.06 |
|
Euro |
1 |
Rs.84.46 |
INFORMATION DETAILS
|
Report
Prepared by : |
NIS |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation
is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.